Longeveron (LGVN) EPS (Weighted Average and Diluted) (QoQ) (2021 - 2026)
Longeveron (LGVN) EPS (Weighted Average and Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Longeveron |
20.35 Bn |
20.33 Bn |
264,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
13.64% |
| Dec 31, 2025 |
43.59% |
| Sep 30, 2025 |
-18.18% |
| Jun 30, 2025 |
2.94% |
| Mar 31, 2025 |
-477.78% |
| Dec 31, 2024 |
126.47% |
| Sep 30, 2024 |
81.42% |
| Jun 30, 2024 |
-13.66% |
| Mar 31, 2024 |
45.05% |
| Dec 31, 2023 |
-5.02% |
| Sep 30, 2023 |
-4.55% |
| Jun 30, 2023 |
-19.02% |
| Mar 31, 2023 |
-954.86% |
| Dec 31, 2022 |
15.07% |
| Sep 30, 2022 |
-24.18% |
| Jun 30, 2022 |
-24.17% |
| Mar 31, 2022 |
23.88% |
| Dec 31, 2021 |
16.93% |
| Sep 30, 2021 |
7.49% |
